StanChart Should Pay and Play
(Bloomberg Gadfly) -- The Bill Winters turnaround at Standard Chartered Plc is now officially a success, with the bank returning to a first-half net profit after last year's loss. With no dividend, however, it's time to take a page out of HSBC Holdings Plc's book and reward investors, and perhaps even start to grow again.
On Wednesday, the specialist emerging-markets lender said underlying operating income for the first six months of 2017 rose 6 percent to $7.2 billion from a year earlier. Underlying pretax profit for the first half increased to $1.9 billion from $994 million, and net profit came in at $971 million.Â
StanChart didn't declare any interim dividend but said the board will review that at the end of the year. While Winters's restructuring is working, HSBC has gone further, and CEO Stuart Gulliver's pivot to Asia is bearing fruit. HSBC's adjusted revenue rose 4 percent for the second quarter ended June 30 and pretax profit climbed 13 percent, beating analysts' estimates. Armed with strong capital buffers, the London-based lender announced a $2 billion buyback earlier this week.Â
To be fair, Winters has his reasons for reticence. The bank's private-equity arm chalked up a $650 million loss last year, having piled into risky assets including an energy company in Nigeria, and at $9.9 billion, its nonperforming loans remain elevated.
But beyond the dividend, which has now been missing for two years, it's StanChart's uncertain growth prospects that should worry shareholders. As part of its Asia push, HSBC has been expanding in the Pearl River Delta; the lender's total China exposure was $158 billion in June, up from $146 billion at the end last year. While scary headlines about China's debt bubble might suggest that's a risky strategy, with a 0.2 percent market share of onshore corporate loans, HSBC can afford to be choosy about customers.
StanChart has the capital strength to emulate the strategy, reporting a robust Tier 1 common equity ratio of 13.8 percent in the first half.
But Winters is still focused on slimming down. Private banking, the one growth engine he badly wants to crank up, is nowhere near his three-year target of $25 billion in new assets. Given the strong competition from regional Asian banks such as DBS Group Holdings Ltd. and Oversea-Chinese Banking Corp., it's unlikely that wealth management will be the ticket to earn an 8 percent return on equity. (Winters scrapped even that modest goal last year.)
Ultimately, StanChart has to find its source of redemption in old-fashioned transaction banking, which generated $1.2 billion in revenue in the first half, up 16 percent from a year earlier. There's room for this to grow.
Bulking up the corporate loan book doesn't mean Winters should return to his predecessor Peter Sands's strategy of lending lumpy sums to Indian and Indonesian conglomerates chasing furious growth in cyclical businesses. If Winters can simply play to the strengths in the lender's 164-year-old DNA, he can pay investors, too. -- With assistance from Andy Mukherjee. This column does not necessarily reflect the opinion of Bloomberg LP and its owners. Nisha Gopalan is a Bloomberg Gadfly columnist covering deals and banking. She previously worked for the Wall Street Journal and Dow Jones as an editor and a reporter. One such borrower is the billionaire Ruia family from India, whose Essar Steel India Ltd. has offered to repay a million offshore loan only after a 25-year moratorium on principal; StanChart is trying to push the firm into bankruptcy to squeeze out more. To contact the editor responsible for this story: Katrina Nicholas at knicholas2@bloomberg.net.
-
The Economic Imperative: Analysing The Material Driving Force Behind India-Canada Strategic Reset
This economic complementarity is further reinforced by deep institutional investment ties and talent mobility, which form the bedrock of the bilateral framework.
-
Medicine Pricing: Where Must Profit Stop?
India must confront excessive margins, hidden incentives and regulatory gaps that threaten the integrity of medicine.
-
Why Amazon And Flipkart Are Struggling To Beat Meesho In India's Smaller Cities
With 274 million users and lowest-cost logistics, Meesho is defending its value commerce crown against giants like Amazon and Flipkart.
-
High US Salaries, No Green Card Certainty: The Financial Calculation Facing Indian H-1B Families
The suspension of PERM processing at eight technology employers does not cancel existing H-1B visas. What it does is force a question many Indian families have been avoiding: is the US salary worth tying your career and family plans to one employer?
-
Swiggy vs Eternal: Food Delivery's Two Rivals Are No Longer In The Same Race
Eternal is building a private AI assistant, dark.ai. Swiggy is still working out how to make Instamart pay, with an operating loss of Rs 895 crore in the July-September quarter while Blinkit stayed profitable.
-
Where You Live Shapes How You Get To Work | The Reason Why
Two-wheelers are the most popular way to get to work in India, accounting for nearly 43% of workplace commutes.
-
Unhedged Position: Can India See An Indonesia-Style Time Correction?
The Nifty is trading below levels it first clocked in 2024. Is there, then, as I have suggested in the headline, potential that the current time correction drags on painfully for the next three-five, even ten years?
-
Navigating Friction And Energy Realities: An Analysis Of Marco Rubio's October Visit To India
Occurring at a critical juncture marked by stalled trade negotiations and escalating geopolitical pressures over global energy supplies, the visit offers a profound window into modern US-India relations.
-
India Exports Capital. Why Not Export Trusteeship?
The big question, then, is whether India can build an institution that global borrowers, investors, banks, and lawyers can trust, even without an Indian connection.
-
France's Economy & Politics Are In Crisis | The Reason Why
Let's look at how the French economy and politics evolved under Nicolas Sarkozy, Franois Hollande and Emmanuel Macron.